Elicio Therapeutics ELTX
NASDAQ ELTX
$1.57 +0.02 (+1.29%)
At close: Oct 20, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Convertible Debt (2024)

Updated

Elicio Therapeutics (ELTX) reported Convertible Debt of $20.03 million for Q4 2024, up 1.0% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Convertible Debt (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Elicio Therapeutics 29.44 Mn -48.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 20.03 Mn
Sep 30, 2024 19.84 Mn
API Access

Elicio Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=ELTX&period=max&api_key=YOUR_API_KEY